These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15115666)

  • 1. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
    Casserly IP; Kereiakes DJ; Gray WA; Gibson PH; Lauer MA; Reginelli JP; Moliterno DJ
    Thromb Res; 2004; 113(2):115-21. PubMed ID: 15115666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time.
    Carroll RC; Chavez JJ; Simmons JW; Snider CC; Wortham DC; Bresee SJ; Cohen E
    Anesth Analg; 2006 May; 102(5):1316-9. PubMed ID: 16632802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
    Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery.
    Zucker ML; Koster A; Prats J; Laduca FM
    J Extra Corpor Technol; 2005 Dec; 37(4):364-8. PubMed ID: 16524153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing management of hirudin anticoagulation.
    Measday MA; Zucker ML; Pan CM; LaDuca FM
    J Extra Corpor Technol; 2005 Mar; 37(1):66-70. PubMed ID: 15804161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
    Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
    J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary intervention.
    Cheneau E; Canos D; Kuchulakanti PK; Rha SW; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2004 Sep; 94(6):789-92. PubMed ID: 15374791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
    Cho L; Kottke-Marchant K; Lincoff AM; Roffi M; Reginelli JP; Kaldus T; Moliterno DJ
    Am J Cardiol; 2003 May; 91(9):1110-3. PubMed ID: 12714157
    [No Abstract]   [Full Text] [Related]  

  • 9. The ecarin clotting time, a universal method to quantify direct thrombin inhibitors.
    Nowak G
    Pathophysiol Haemost Thromb; 2003 Jul-2004 Aug; 33(4):173-83. PubMed ID: 15583446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors.
    Van Cott EM; Roberts AJ; Dager WE
    Semin Thromb Hemost; 2017 Apr; 43(3):270-276. PubMed ID: 28052306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
    Demir M; Iqbal O; Untch B; Hoppensteadt DA; Gaikwad BS; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of anticoagulant effects of direct thrombin inhibitors.
    Fenyvesi T; Jörg I; Harenberg J
    Semin Thromb Hemost; 2002 Aug; 28(4):361-8. PubMed ID: 12244483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
    Pötzsch B; Hund S; Madlener K; Unkrig C; Müller-Berghaus G
    Thromb Res; 1997 Jun; 86(5):373-83. PubMed ID: 9211628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time].
    Kher A; Gouin I; Samama MM
    Ann Biol Clin (Paris); 2000; 58(5):575-9. PubMed ID: 11022100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
    Moser M; Ruef J; Peter K; Kohler B; Gulba DC; Paterna N; Nordt T; Kübler W; Bode C
    J Thromb Thrombolysis; 2001 Oct; 12(2):165-9. PubMed ID: 11729368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the i-STAT handheld activated clotting time for use with bivalirudin.
    Schussler JM; Lander SR; Wissinger LA; Anwar A; Donsky MS; Johnson KB; Vallabhan RC; Wischmeyer JB
    Am J Cardiol; 2004 May; 93(10):1318-9. PubMed ID: 15135717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
    Choi TS; Khan AI; Greilich PE; Kroll MH
    Am J Clin Pathol; 2006 Feb; 125(2):290-5. PubMed ID: 16393689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
    Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
    Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center.
    Gurm HS; Rajagopal V; Fathi R; Vivekanathan D; Yadav JS; Bhatt DL; Ellis SG; Lincoff AM; Topol EJ
    Am J Cardiol; 2005 Mar; 95(6):716-21. PubMed ID: 15757596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.